Outcomes after partially covered self-expandable metal stent placement for recurrent duodenal obstruction. 2023

Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Outcomes of partially covered self-expandable metal stents (SEMS) as an additional stent after recurrent duodenal obstruction (RDO) have not been elucidated. In this study, we compared outcomes of partially covered and uncovered SEMS placement after RDO in patients with malignant duodenal obstruction and explored factors affecting re-recurrent obstruction and overall survival in this population. We conducted a retrospective study of patients undergoing SEMS placement for RDO at a cancer institute in Japan from July 2014 to June 2021. Clinical variables and outcomes of patients undergoing partially covered and uncovered SEMS placement were compared. Sixty-one patients underwent SEMS placement after RDO, for which the COMVI stent was used in 38 cases and uncovered stents were used in 23 cases. Stent ingrowth was the most common cause of RDO (51.4%). Stent migration only occurred after partially covered stent placement (20% vs. 0%, p = 0.018). Choice of SEMS had no impact on time to re-RDO (median 2.8 vs. 4.1 months, p = 0.776) or overall survival (median 2.6 vs. 2.4 months, p = 0.703). Median overall survival was longer in patients receiving chemotherapy after second stenting (4.6 vs. 1.8 months, p < 0.001) and shorter in those with early RDO, regardless of the SEMS used. Use of the partially covered stent had no impact on survival or time to RDO. While outcomes after partially covered SEMS placement for RDO were not significantly different from uncovered SEMS, migration remains a concern when they are used as a second stent. Chemotherapy after second stenting was associated with longer overall survival but not with longer time to re-RDO.

UI MeSH Term Description Entries
D010166 Palliative Care Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed) Palliative Treatment,Palliative Supportive Care,Palliative Surgery,Palliative Therapy,Surgery, Palliative,Therapy, Palliative,Care, Palliative,Palliative Treatments,Supportive Care, Palliative,Treatment, Palliative,Treatments, Palliative
D004380 Duodenal Obstruction Hindrance of the passage of luminal contents in the DUODENUM. Duodenal obstruction can be partial or complete, and caused by intrinsic or extrinsic factors. Simple obstruction is associated with diminished or stopped flow of luminal contents. Strangulating obstruction is associated with impaired blood flow to the duodenum in addition to obstructed flow of luminal contents. Duodenal Obstructions,Obstruction, Duodenal,Obstructions, Duodenal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069322 Self Expandable Metallic Stents Cylindrical metallic tubes that are inserted to hold open a structure in order to treat vascular, bile duct, esophageal and other tubular organ constrictions. Self Expandable Metal Stent,Self Expandable Metal Stents,Self Expandable Metallic Stent
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015607 Stents Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting. Stent
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
December 2017, Endoscopy international open,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
February 2015, World journal of gastroenterology,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
October 2019, Endoscopy,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
March 1990, Lancet (London, England),
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
January 2023, Internal medicine (Tokyo, Japan),
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
April 2023, Journal of gastrointestinal and liver diseases : JGLD,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
December 2015, European journal of gastroenterology & hepatology,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
September 2017, Journal of surgical case reports,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
November 2014, World journal of gastroenterology,
Takeshi Okamoto, and Takashi Sasaki, and Toshiyuki Yoshio, and Chinatsu Mori, and Takafumi Mie, and Takaaki Furukawa, and Yuto Yamada, and Tsuyoshi Takeda, and Akiyoshi Kasuga, and Masato Matsuyama, and Masato Ozaka, and Junko Fujisaki, and Naoki Sasahira
November 2014, Endoscopy,
Copied contents to your clipboard!